Mainz Biomed (MYNZ) News Today $5.74 +0.14 (+2.50%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$5.74 +0.00 (+0.07%) As of 02/21/2025 07:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Mainz Biomed expands into Switzerland with labor team laboratory partnershipFebruary 20 at 11:20 AM | markets.businessinsider.comMainz Biomed expands into Switzerland with labor team wFebruary 20 at 9:10 AM | seekingalpha.comMainz Biomed Partners with labor team w ag to Launch ColoAlert® Colorectal Cancer Screening Test in SwitzerlandFebruary 20 at 8:46 AM | quiverquant.comMainz Biomed Expands into Switzerland with labor team wFebruary 20 at 8:01 AM | globenewswire.comMainz Biomed (NASDAQ:MYNZ) Research Coverage Started at Maxim GroupFebruary 17, 2025 | americanbankingnews.comMaxim Group Initiates Coverage of Mainz Biomed N.V. (MYNZ) with Buy RecommendationFebruary 15, 2025 | msn.comMaxim starts Mainz Biomed at Buy on CRC screening potentialFebruary 14, 2025 | markets.businessinsider.comMainz Biomed initiated with a Buy at MaximFebruary 14, 2025 | markets.businessinsider.comMainz Biomed, GANZIMMUN launch enhanced ColoAlert CRC screening testFebruary 11, 2025 | markets.businessinsider.comMainz Biomed Collaborates with GANZIMMUN Diagnostics to Launch Enhanced ColoAlert Colorectal Cancer Screening Test in GermanyFebruary 11, 2025 | quiverquant.comMainz Biomed and GANZIMMUN Announce Launch of Enhanced ColoAlert Colorectal Cancer Screening Ahead of Awareness MonthFebruary 11, 2025 | globenewswire.comMainz Biomed Regains Compliance With Nasdaq Listing RulesJanuary 27, 2025 | markets.businessinsider.comMainz BioMed NV: Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing RequirementsJanuary 27, 2025 | finanznachrichten.deEQS-News: Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing RequirementsJanuary 27, 2025 | markets.businessinsider.comMainz Biomed regains Nasdaq compliance with equity ruleJanuary 27, 2025 | msn.comMainz Biomed Regains Nasdaq Listing ComplianceJanuary 27, 2025 | tipranks.comMainz Biomed Regains Compliance with Nasdaq Listing RequirementsJanuary 27, 2025 | quiverquant.comMainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing RequirementsJanuary 27, 2025 | globenewswire.comMainz Biomed Moves Forward With Pivotal CRC Study After Feasibility TrialJanuary 21, 2025 | markets.businessinsider.comMainz Biomed initiates U.S. study to evaluate CRC testJanuary 21, 2025 | markets.businessinsider.comMainz Biomed Launches eAArly DETECT 2 Feasibility Study for Next Generation Colorectal Cancer TestJanuary 21, 2025 | quiverquant.comMainz Biomed Initiates U.S. Clinical Study to Evaluate Performance of Next Generation Test on Advanced Adenomas over Large Patient PopulationJanuary 21, 2025 | globenewswire.comMainz Biomed B.V. Addresses Nasdaq Listing Compliance IssueJanuary 14, 2025 | tipranks.comMainz Biomed partners with Quest for colorectal cancer screening testDecember 21, 2024 | msn.comMainz Biomed, Quest Diagnostics To Commercialize NextGen Colorectal Cancer Screening Test; Stock UpDecember 20, 2024 | markets.businessinsider.comMainz Biomed forms agreement with Quest DiagnosticsDecember 20, 2024 | markets.businessinsider.comMainz Biomed Enters Agreement with Quest Diagnostics to Advance ColoAlert Colorectal Cancer Screening TestDecember 19, 2024 | quiverquant.comQuest Diagnostics (NYSE: DGX) And Mainz Biomed (NASDAQ: MYNZ) Team Up To Commercialize ColoAlert Early Cancer Detection Screening In The U.S.December 19, 2024 | benzinga.comMainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening TestDecember 19, 2024 | globenewswire.comMainz Biomed-Aktie erreicht 52-Wochen-Tief bei 4,3 US-DollarDecember 18, 2024 | de.investing.comMainz BioMed NV: Mainz Biomed Announces Closing of $8.0 Million Follow-On OfferingDecember 17, 2024 | finanznachrichten.deMainz Biomed Secures $8 Million in Follow-On OfferingDecember 17, 2024 | markets.businessinsider.comMainz Biomed N.V. Completes Follow-On Offering Raising Approximately $8 MillionDecember 16, 2024 | quiverquant.comMainz Biomed Announces Closing of $8.0 Million Follow-On OfferingDecember 16, 2024 | globenewswire.comMainz Biomed NV trading halted, volatility trading pauseDecember 16, 2024 | tipranks.comMainz Biomed NV trading resumesDecember 16, 2024 | tipranks.comMainz BioMed NV: Mainz Biomed Announces Pricing of $8.0 Million Follow-On Offering Priced at-the-Market Under Nasdaq RulesDecember 14, 2024 | finanznachrichten.deMainz Biomed Prices $8 Million Follow-On Offering to Boost Diagnostics OperationsDecember 13, 2024 | tipranks.comMainz Biomed prices $8.0M at-the-market offering at $5.85 per unitDecember 13, 2024 | tipranks.comMainz Biomed prices $8M offering of shares and warrantsDecember 13, 2024 | seekingalpha.comMainz Biomed N.V. Announces Pricing of Follow-On Offering to Raise Approximately $8.0 MillionDecember 12, 2024 | quiverquant.comMainz Biomed Announces Pricing of $8.0 Million Follow-On Offering Priced at-the-Market Under Nasdaq RulesDecember 12, 2024 | globenewswire.comMainz Biomed-Aktie erreicht 52-Wochen-Tief bei 6,12 US-DollarDecember 10, 2024 | de.investing.comMainz Biomed stock hits 52-week low at $6.12 amid market challengesDecember 10, 2024 | investing.comMainz Biomed Announces Reverse Stock Split Soon After Collaborating With MedTech Giant Thermo Fisher ScientificDecember 3, 2024 | benzinga.comMainz Biomed Announces Reverse Stock Split Soon After Collaborating With MedTech Giant Thermo Fisher ScientificDecember 3, 2024 | benzinga.comMainz Biomed NV trading halted, news pendingDecember 2, 2024 | tipranks.comMainz BioMed NV: Mainz Biomed Announces Stock SplitDecember 2, 2024 | finanznachrichten.deMainz Biomed-Aktie erreicht 52-Wochen-Tief bei 0,18 US-DollarDecember 2, 2024 | de.investing.comMainz Biomed $MYNZ & Thermo Fisher Partner On Next-Gen Colorectal Cancer Screening ProductNovember 29, 2024 | msn.com Get Mainz Biomed News Delivered to You Automatically Sign up to receive the latest news and ratings for MYNZ and its competitors with MarketBeat's FREE daily newsletter. Email Address MYNZ Media Mentions By Week MYNZ Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MYNZ News Sentiment▼-0.200.60▲Average Medical News Sentiment MYNZ News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MYNZ Articles This Week▼62▲MYNZ Articles Average Week Get Mainz Biomed News Delivered to You Automatically Sign up to receive the latest news and ratings for MYNZ and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Ovid Therapeutics News Generation Bio News Eliem Therapeutics News ImmuCell News FibroBiologics News NRx Pharmaceuticals News OncoCyte News Spero Therapeutics News Estrella Immunopharma News Barinthus Biotherapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MYNZ) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mainz Biomed Please log in to your account or sign up in order to add this asset to your watchlist. Share Mainz Biomed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
